IL-6 is generally recognized as a pro-inflammatory cytokine, but it also plays a role in lowering pro-inflammatory activity by releasing soluble TNF receptors; therefore, the balance of IL-6 activity is critical in the pathogenesis of atherosclerosis [16]. This evidence concerns the gene IL6 and atherosclerosis.